FR2944796B1 - Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant - Google Patents

Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant

Info

Publication number
FR2944796B1
FR2944796B1 FR0901981A FR0901981A FR2944796B1 FR 2944796 B1 FR2944796 B1 FR 2944796B1 FR 0901981 A FR0901981 A FR 0901981A FR 0901981 A FR0901981 A FR 0901981A FR 2944796 B1 FR2944796 B1 FR 2944796B1
Authority
FR
France
Prior art keywords
hydrolysats
lightening
peptide
compositions containing
containing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0901981A
Other languages
English (en)
Other versions
FR2944796A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Jean Marie Botto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISP Investments LLC
Original Assignee
ISP Investments LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISP Investments LLC filed Critical ISP Investments LLC
Priority to FR0901981A priority Critical patent/FR2944796B1/fr
Publication of FR2944796A1 publication Critical patent/FR2944796A1/fr
Application granted granted Critical
Publication of FR2944796B1 publication Critical patent/FR2944796B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/06—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/10—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cosmetics (AREA)
FR0901981A 2009-04-23 2009-04-23 Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant Active FR2944796B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0901981A FR2944796B1 (fr) 2009-04-23 2009-04-23 Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0901981A FR2944796B1 (fr) 2009-04-23 2009-04-23 Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant

Publications (2)

Publication Number Publication Date
FR2944796A1 FR2944796A1 (fr) 2010-10-29
FR2944796B1 true FR2944796B1 (fr) 2013-08-02

Family

ID=41490424

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0901981A Active FR2944796B1 (fr) 2009-04-23 2009-04-23 Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant

Country Status (1)

Country Link
FR (1) FR2944796B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2951947B1 (fr) * 2009-11-03 2022-01-07 Isp Investments Inc Utilisation d'une composition comprenant un extrait peptidique de riz non fermente pour stimuler la pousse des cheveux
FR2975909B1 (fr) * 2011-05-31 2013-07-12 Isp Investments Inc Extrait de riz et de kamut en combinaison en tant qu'agent actif unifiant la peau

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2822701B1 (fr) * 2001-04-03 2005-03-18 Lvmh Rech Utilisation d'un extrait d'algue phaeodactylum comme agent cosmetique favorisant l'activite du proteasome des cellules de la peau et composition cosmetique le contenant
FR2869228B1 (fr) * 2004-04-21 2008-09-05 Vincience Sa Utilisation d'un hydrolysat de proteines de cruciferes en tant qu'agent depigmentant dans ou pour une composition cosmetique et/ou pharmaceutique
FR2903903B1 (fr) * 2006-07-18 2008-08-29 Expanscience Laboratoires Sa Utilisation d'un hydrolysat de proteines de riz en tant que principe actif pigmentant
FR2904552B1 (fr) * 2006-08-03 2012-09-21 Soc Extraction Principes Actif Utilisation d'un extrait de levure en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes
WO2008015343A2 (fr) * 2006-08-03 2008-02-07 Societe D'extraction Des Principes Actifs Sa (Vincience) Utilisation d'un extrait de levure en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes
FR2915379B1 (fr) * 2007-04-27 2012-07-13 Vincience Utilisation d'un principe actif issu du riz (oryza sativa l) pour preparer une composition destinee a proteger les mitochondries
FR2915384B1 (fr) * 2007-04-27 2010-01-15 Vincience Utilisation d'un principe actif issu du soja (glycine maxl.) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
FR2915383B1 (fr) * 2007-04-27 2010-01-15 Vincience Utilisation d'un principe actif issu du riz (oryza sativa l.) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
FR2915381B1 (fr) * 2007-04-27 2012-06-08 Vincience Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c
FR2915380B1 (fr) * 2007-04-27 2012-06-08 Vincience Utilisateur d'un principe actif issu du riz (oryza sativa l) pour preparer une composition destinee a activer le cytochrome c
FR2915378B1 (fr) * 2007-04-27 2009-08-21 Vincience Sa Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries
FR2915382B1 (fr) * 2007-04-27 2012-06-01 Vincience Utilisation d'un principe actif issu du mais (zea mays l) pour preparer une composition destinee a activer le cytochrome c

Also Published As

Publication number Publication date
FR2944796A1 (fr) 2010-10-29

Similar Documents

Publication Publication Date Title
FR2944797B1 (fr) Hydrolysats peptidiques activateurs du proteasome et compositions les contenant
HK1203929A1 (en) Inhibitors of hcv ns5a hcv ns5a
HK1208686A1 (en) Aromatic-cationic peptides and uses of same
IL233024A0 (en) Preparations and methods for using proislet proteins and their analogs
ZA201104911B (en) Inhibitors of hcv ns5a
DK1996621T3 (da) Antistoffer mod beta-amyloid-peptid
ATE483651T1 (de) Schnellfrierender behälter und versiegelung dafür
EP2575866A4 (fr) Inhibiteurs de ns5a du vhc
EP2373679A4 (fr) Mini peptides d'hépcidine et leurs procédés d'utilisation
EP2575475A4 (fr) Inhibiteurs de ns5a de vhc
EP2618665A4 (fr) Inhibiteurs de protéase ns3 du vhc
EP2566880A4 (fr) Peptides aromatiques-cationiques et leurs applications
IL219470A0 (en) Compositions containing fractalknie-binding proteins and uses thereof
EP2421901A4 (fr) Composition contenant le complexe hc ha et procédés d'utilisation de celle-ci
FR2944798B1 (fr) Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant
IL225908A0 (en) New specific inhibitors for 3ns hcv protease
IL216223A0 (en) Methods of analyzing peptide mixtures
EP2270141A4 (fr) Peptide partiel de la lacritine
FR2944016B1 (fr) Nouveaux peptides anti-age activateurs du proteasome et compositions les contenant
DK2352677T3 (da) Emballagemateriale med forperforering
FR2944018B1 (fr) Nouveaux peptides anti-age activateurs du proteasome et compositions les contenant
FR2946347B1 (fr) Agents anti-age et compositions les contenant
FR2944796B1 (fr) Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant
HK1151242A1 (en) Mntf peptide compositions and methods of use mntf
FR2944795B1 (fr) Hydrolysats peptidiques activateurs du proteasome et compositions les contenant

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16